Principles and practice of pharmaceutical medicine / (Record no. 27888)

MARC details
000 -LEADER
fixed length control field 03791cam a22003254a 4500
001 - CONTROL NUMBER
control field 1155970
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20160912120251.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 031014s2002 xxk eng
010 ## -
-- 2001024251
015 ## -
-- GBA2-52177
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0471986550
035 ## -
-- (Sirsi) i0471986550
040 ## -
-- DLC
-- DLC
-- C#P
-- UKM
042 ## -
-- pcc
-- nlmcopyc
049 ## -
-- NLMM
050 00 -
-- RM301.25
-- .P75 2002
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 736 2002PR
082 00 -
-- 615/.19
-- 21
245 00 - TITLE STATEMENT
Title Principles and practice of pharmaceutical medicine /
Statement of responsibility, etc. Andrew J. Fletcher ... [et al., editors].
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. Chichester, UK :
Name of publisher, distributor, etc. Wiley,
Date of publication, distribution, etc. 2002.
300 ## - PHYSICAL DESCRIPTION
Extent xii, 541 p. :
Other physical details ill. ;
Dimensions 25 cm.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Overview of Pharmaceutical Medicine -- Pharmaceutical medicine as a medical speciality / Michael D Young -- What pharmaceutical medicine is and who does it / W Wardell and Susan Toland -- Competency-based training system for clinical research staff / Jay D Miller -- Drug Discover and Development: Introduction / Tony Fox and Lionel Edwards -- Design and Serendipity / Leslie J Molony -- Pharmaceutics / Anthony W. Fox -- Non-clinical toxicology / Frederick Reno -- Informed consent / Anthony W Fox -- Good Clinical Practices / Wendy Bohaychuk and Graham Ball -- Quality Assurance, quality control and audit / Donna Cullen -- Phase I: The first opportunity for extrapolation from animal data to human experience / Stephen Cyrt, Dennis McCarthy, Helen Heyn, Matthew Marler and Johan Gabrielsson -- Phase II and Phase III clinical studies / Anthony W Fox -- Phase IV development: Post-marketing studies / Lisa R Johnson-Pratt -- Over-the counter medicines / Paul Starkey -- Special Populations / Lionel D Edwards -- Biotechnology products and their development / David Shapiro and Anthony W Fox -- Orphan drugs / Bert Spilker -- Pharmacoeconomics: Economic evaluation and Humanistic outcomes / Raymond J Townsend, Jane T Osterhaus and J Gregory Boyer -- Pharmacoepidemiology and the pharmaceutical physician / Hugh Tilson -- Statistical principles and their application in bio-pharmaceutical research / Dan Anbar -- Data Management / Ty Lee and Michael Minor -- Patient compliance / Jean-Michel Metry -- Complementary medicine / Anthony W. Fox -- Drug Registration: Introduction / Anthony W Fox -- US Regulation / William Kennedy -- Emergency and compassionate-use INDs and accelerated NDA and ANDA approvals - Procedures, benefits and pitfalls / Anthony W Fox -- Japanese Regulations / Etienne Labbe -- EC Regulations / John Griffin -- International Committee on Harmonisation / Lionel D Edwards -- Medical Services -- Advertising Material / Gill Price -- Drug Labelling / Anthony W Fox -- Scientific Conferences / Z Dziewanovska -- Drug Surveillance / Howard J Dreskin and Win M Castle -- Disease Management - what does it mean / Roy Lilley -- Publishing Clinical Studies / Anthony W Fox -- Legal and Ethical Aspects: Introduction / Sara Croft and T Pratt -- Pharmaceutical product liability / Han W Choi and Howard B Yeon -- Patents / Gabriel Lopez -- Fraud and misconduct in clinical research / Frank Wells -- Business Aspects -- The Multinational Corporations: Cultural challenges, the legal/regulatory framework and the medico-commercial environment / R Drucker and RG Hughes -- Outsourcing clinical drug development activities to contract research organisation: Critical success factors / John R Vogel -- Third World / G Hammad -- Financial aspects of clinical trials / R G Hughes and N Brancaccio -- The Impact of Managed Care on the US Pharmaceutical Industry / Robert J Chaponis ... et al
596 ## -
-- 4
650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug industry
General subdivision organization and administration.
650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug evaluation.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fletcher, Andrew J.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme NLM Classification Scheme
Koha item type Books
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Cost, normal purchase price Total Checkouts Full call number Barcode Date last seen Copy number Bill Date Koha item type Permanent Item
    NLM Classification Scheme     WHO HQ WHO HQ BORROWABLE-COLL-STACKS 10/10/2003 2.00   QV 736 2002PR 00076297 12/09/2016 1 12/09/2016 Books Y
Implemented & Customized by: OpenLX

Powered by Koha